EPSILON HEALTHCARE LIMITED (EPN)

---

AI Coverage Rating: Low

ASX AI Signals has generated 0 signals for EPN during the last 90 days, indicating low trading activity

EPN Share Price
Current Price	$0.022
52 Week High	$0.038
52 Week Low:	$0.019
Trading at (% of 52 Week High)	57.89%

Business Overview

Epsilon Healthcare Limited (ASX: EPN) is an Australian company that supplies pharmaceutical products and healthcare equipment. The company focuses on developing, marketing, and distributing a range of generic medicines and nutritional products for the healthcare sector.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The SELL recommendation for EPN is supported by weak price performance and potential liquidity concerns at the current low price level. However, limited publicly available fundamental data and market volatility introduce some uncertainty, moderating the confidence level.

Latest  EPSILON HEALTHCARE LIMITED(EPN)   News